Navidea Biopharmaceuticals PE Ratio 2006-2018 | NAVB
Current and historical p/e ratio for Navidea Biopharmaceuticals (NAVB) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Navidea Biopharmaceuticals PE ratio as of March 18, 2019 is 0.00.
| Navidea Biopharmaceuticals PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2019-03-18 | 0.13 | 0.00 | |
| 2018-09-30 | 0.23 | $-0.11 | 0.00 |
| 2018-06-30 | 0.23 | $-0.10 | 0.00 |
| 2018-03-31 | 0.36 | $-0.11 | 0.00 |
| 2017-12-31 | 0.36 | $0.45 | 0.80 |
| 2017-09-30 | 0.42 | $0.46 | 0.90 |
| 2017-06-30 | 0.51 | $0.47 | 1.09 |
| 2017-03-31 | 0.58 | $0.46 | 1.25 |
| 2016-12-31 | 0.64 | $-0.08 | 0.00 |
| 2016-09-30 | 0.92 | $-0.08 | 0.00 |
| 2016-06-30 | 0.53 | $-0.13 | 0.00 |
| 2016-03-31 | 0.94 | $-0.15 | 0.00 |
| 2015-12-31 | 1.33 | $-0.18 | 0.00 |
| 2015-09-30 | 2.28 | $-0.21 | 0.00 |
| 2015-06-30 | 1.61 | $-0.21 | 0.00 |
| 2015-03-31 | 1.59 | $-0.22 | 0.00 |
| 2014-12-31 | 1.89 | $-0.25 | 0.00 |
| 2014-09-30 | 1.32 | $-0.30 | 0.00 |
| 2014-06-30 | 1.48 | $-0.34 | 0.00 |
| 2014-03-31 | 1.85 | $-0.36 | 0.00 |
| 2013-12-31 | 2.07 | $-0.34 | 0.00 |
| 2013-09-30 | 2.65 | $-0.31 | 0.00 |
| 2013-06-30 | 2.67 | $-0.31 | 0.00 |
| 2013-03-31 | 2.71 | $-0.28 | 0.00 |
| 2012-12-31 | 2.83 | $-0.29 | 0.00 |
| 2012-09-30 | 2.75 | $-0.30 | 0.00 |
| 2012-06-30 | 3.72 | 0 | 0.00 |
| 2012-03-31 | 3.28 | $0.04 | 82.00 |
| 2011-12-31 | 2.62 | $0.06 | 43.67 |
| 2011-09-30 | 2.96 | $0.11 | 26.91 |
| 2011-06-30 | 3.32 | $-0.13 | 0.00 |
| 2011-03-31 | 3.95 | $-0.75 | 0.00 |
| 2010-12-31 | 2.06 | $-0.73 | 0.00 |
| 2010-09-30 | 1.88 | $-0.70 | 0.00 |
| 2010-06-30 | 1.80 | $-1.01 | 0.00 |
| 2010-03-31 | 1.64 | $-0.58 | 0.00 |
| 2009-12-31 | 1.22 | $-0.54 | 0.00 |
| 2009-09-30 | 1.40 | $-0.56 | 0.00 |
| 2009-06-30 | 0.95 | $-0.25 | 0.00 |
| 2009-03-31 | 0.54 | $-0.05 | 0.00 |
| 2008-12-31 | 0.57 | $-0.08 | 0.00 |
| 2008-09-30 | 0.57 | $-0.09 | 0.00 |
| 2008-06-30 | 0.68 | $-0.07 | 0.00 |
| 2008-03-31 | 0.35 | $-0.08 | 0.00 |
| 2007-12-31 | 0.29 | $-0.08 | 0.00 |
| 2007-09-30 | 0.31 | $-0.07 | 0.00 |
| 2007-06-30 | 0.27 | $-0.09 | 0.00 |
| 2007-03-31 | 0.24 | $-0.08 | 0.00 |
| 2006-12-31 | 0.24 | $-0.08 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.026B | $0.001B |
| Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $105.149B | 23.70 |
| Intuitive Surgical (ISRG) | United States | $64.544B | 60.29 |
| Edwards Lifesciences (EW) | United States | $39.661B | 40.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.173B | 16.55 |
| IDEXX Laboratories (IDXX) | United States | $18.555B | 50.53 |
| ABIOMED (ABMD) | United States | $15.025B | 99.18 |
| Teleflex (TFX) | United States | $13.856B | 30.38 |
| Hologic (HOLX) | United States | $13.744B | 20.78 |
| DexCom (DXCM) | United States | $13.154B | 503.96 |
| Varian Medical Systems (VAR) | United States | $12.307B | 30.74 |
| STERIS (STE) | United Kingdom | $10.424B | 26.79 |
| Masimo (MASI) | United States | $7.034B | 43.79 |
| Penumbra (PEN) | United States | $5.275B | 298.45 |
| Integra LifeSciences Holdings (IART) | United States | $4.747B | 23.02 |
| Globus Medical (GMED) | United States | $4.684B | 28.43 |
| LivaNova (LIVN) | United Kingdom | $4.643B | 28.38 |
| Tandem Diabetes Care (TNDM) | United States | $4.116B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $4.048B | 0.00 |
| Cantel Medical (CMD) | United States | $2.797B | 27.81 |
| Integer Holdings (ITGR) | United States | $2.795B | 22.80 |
| Glaukos (GKOS) | United States | $2.642B | 0.00 |
| Inogen (INGN) | United States | $2.088B | 41.61 |
| AVANOS MEDICAL, INC (AVNS) | United States | $2.041B | 22.17 |
| OPKO Health (OPK) | United States | $1.551B | 0.00 |
| Nevro (NVRO) | United States | $1.349B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.170B | 222.11 |
| Pacific Biosciences Of California (PACB) | United States | $1.110B | 0.00 |
| CryoLife (CRY) | United States | $1.099B | 118.44 |
| Accelerate Diagnostics (AXDX) | United States | $1.089B | 0.00 |
| Luminex (LMNX) | United States | $1.072B | 48.98 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $1.071B | 29.11 |
| Intersect ENT (XENT) | United States | $1.036B | 0.00 |
| Natus Medical (BABY) | United States | $0.913B | 19.03 |
| Mesa Laboratories (MLAB) | United States | $0.898B | 36.74 |
| Veracyte (VCYT) | United States | $0.898B | 0.00 |
| AxoGen (AXGN) | United States | $0.837B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.814B | 26.40 |
| ViewRay (VRAY) | United States | $0.790B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.661B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.613B | 0.00 |
| Fluidigm (FLDM) | United States | $0.543B | 0.00 |
| TransEnterix (TRXC) | United States | $0.510B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.475B | 50.03 |
| Si-Bone (SIBN) | United States | $0.459B | 0.00 |
| Accuray (ARAY) | United States | $0.410B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.408B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.385B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.378B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.370B | 54.00 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| IRadimed (IRMD) | United States | $0.281B | 59.42 |
| SeaSpine Holdings (SPNE) | United States | $0.273B | 0.00 |
| Sientra (SIEN) | United States | $0.269B | 0.00 |
| Nuvectra (NVTR) | United States | $0.225B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.210B | 48.67 |
| Helius Medical Technologies (HSDT) | United States | $0.160B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.159B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.137B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.130B | 0.00 |
| ConforMIS (CFMS) | United States | $0.127B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.119B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.118B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.104B | 0.00 |
| Vermillion (VRML) | United States | $0.100B | 0.00 |
| SOLITON INC (SOLY) | $0.091B | 0.00 | |
| EDAP TMS (EDAP) | France | $0.086B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.073B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.072B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.068B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.051B | 0.00 |
| Avinger (AVGR) | United States | $0.044B | 0.00 |
| Electromed (ELMD) | United States | $0.044B | 22.83 |
| Xtant Medical Holdings (XTNT) | United States | $0.041B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.039B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.035B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.034B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.030B | 0.00 |
| PAVmed (PAVM) | United States | $0.029B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.025B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.025B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.023B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.019B | 63.02 |
| Dynatronics (DYNT) | United States | $0.018B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.017B | 0.00 |
| Presbia (LENS) | Ireland | $0.016B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.016B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.015B | 0.00 |
| Neovasc (NVCN) | Canada | $0.013B | 0.00 |
| Micron Solutions (MICR) | United States | $0.009B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.007B | 0.00 |
| InspireMD (NSPR) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.002B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
